CV Sciences (CVSI) Change in Account Payables (2011 - 2013)
CV Sciences (CVSI) posted Change in Account Payables of $280538.0 for Q1 2013, up 1140.76% sequentially from -$26955.0 in Q4 2012, and up 2825.01% YoY from $9591.0 in Q1 2012.
CV Sciences (CVSI) Change in Account Payables (2011 - 2013) Analysis & Trends
CV Sciences has reported Change in Account Payables for 3 years, with the latest figure at $280538.0 in Q1 2013.
- Quarterly Change in Account Payables rose 2825.01% year-over-year to $280538.0 in Q1 2013, while the trailing twelve-month figure through Mar 2013 was $250724.0 (up 1287.52% YoY) and the FY2015 annual result came in at $113021.0, down 40.78% from the prior year.
- Change in Account Payables advanced to $280538.0 in Q1 2013 per CVSI's latest filing, from -$26955.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $280538.0 in Q1 2013 and troughed at -$26955.0 in Q4 2012.
- A 3-year average of $31170.9 and a median of $3386.0 in 2011 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2012 and 2013: Change in Account Payables plunged 178.46% in 2012, then surged 2825.01% in 2013.
- Over 3 years, Change in Account Payables stood at -$9680.0 in 2011, then plunged by 178.46% to -$26955.0 in 2012, then soared by 1140.76% to $280538.0 in 2013.
- According to Business Quant data, Change in Account Payables over the past three periods registered $280538.0, -$26955.0, and -$2411.0 for Q1 2013, Q4 2012, and Q3 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 280,538.00 |
| Mar 31, 2013 | 280,538.00 |
| Dec 31, 2012 | -26,955.00 |
| Dec 31, 2012 | -26,955.00 |
| Sep 30, 2012 | -2,411.00 |
| Sep 30, 2012 | -2,411.00 |
| Jun 30, 2012 | -448.00 |
| Jun 30, 2012 | -448.00 |
| Mar 31, 2012 | 9,591.00 |
| Mar 31, 2012 | 9,591.00 |
| Dec 31, 2011 | -9,680.00 |
| Dec 31, 2011 | -9,680.00 |
| Sep 30, 2011 | 14,773.00 |
| Sep 30, 2011 | 14,773.00 |
| Jun 30, 2011 | 3,386.00 |
| Jun 30, 2011 | 3,386.00 |
| Mar 31, 2011 | 11,744.00 |
| Mar 31, 2011 | 11,744.00 |